Todd Goldberg
About Todd Goldberg
Todd Goldberg serves as the Vice President of Market Access at Deciphera Pharmaceuticals, bringing extensive experience from previous roles at Amgen, Agios Pharmaceuticals, and Clovis Oncology. He holds degrees in Bioengineering and Biomedical Engineering from the University of Pennsylvania and Northwestern University, respectively, as well as an MBA from Harvard Business School.
Current Role at Deciphera Pharmaceuticals
Todd Goldberg serves as the Vice President of Market Access at Deciphera Pharmaceuticals. He has held this position since 2020, contributing to the company's strategic initiatives in Waltham, Massachusetts. His role focuses on developing and implementing market access strategies to enhance the availability of Deciphera's therapeutic products.
Previous Experience at Amgen
Goldberg has an extensive background with Amgen, where he held multiple executive roles. He served as Executive Director of Corporate Accounts and Payor Reimbursement from 2011 to 2014. Prior to that, he was Executive Director of PPM Sales and Marketing from 2003 to 2006, and later as Executive Director of Marketing from 2006 to 2011. His tenure at Amgen spanned over a decade, during which he developed significant expertise in market access and pharmaceutical marketing.
Experience at Agios Pharmaceuticals and Clovis Oncology
At Agios Pharmaceuticals, Todd Goldberg was Vice President of Market Access from 2016 to 2020. His role involved overseeing market access strategies in Cambridge, MA. Additionally, he worked at Clovis Oncology as Vice President of Market Access from 2014 to 2016, where he focused on developing market strategies in Boulder, CO. His experience in these roles contributed to his comprehensive understanding of the market access landscape.
Educational Background in Bioengineering and Management
Todd Goldberg studied Bioengineering at the University of Pennsylvania, earning a Bachelor of Science in Engineering (BSE) from 1983 to 1986. He furthered his education at Northwestern University, where he obtained a Master of Science in Engineering (MSE) in Biomedical Engineering from 1986 to 1989. Additionally, he completed an MBA in General Management at Harvard Business School from 1991 to 1993. This educational foundation supports his expertise in the pharmaceutical and biotech industries.
Expertise in Market Access and Contract Negotiations
Goldberg possesses extensive experience in developing distribution and pharmacy channel strategies. He has led cross-functional teams in creating life-cycle management strategies across various therapeutic areas. His expertise also includes contract negotiations within the pharmaceutical and biotech sectors, which is critical for establishing and maintaining market access.